STK17B Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant STK17B.
- 产品详情
- 实验流程
Application ![]()
| WB, IHC, IF, E |
---|---|
Primary Accession | O94768 |
Other Accession | BC016040 |
Reactivity | Human |
Host | mouse |
Clonality | monoclonal |
Isotype | IgG2b Kappa |
Clone Names | 2C3 |
Calculated MW | 42344 Da |
Gene ID | 9262 |
---|---|
Other Names | Serine/threonine-protein kinase 17B, DAP kinase-related apoptosis-inducing protein kinase 2, STK17B, DRAK2 |
Target/Specificity | STK17B (AAH16040, 272 a.a. ~ 372 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. |
Dilution | WB~~1:500~1000 IHC~~1:100~500 IF~~1:50~200 E~~N/A |
Format | Clear, colorless solution in phosphate buffered saline, pH 7.2 . |
Storage | Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
Precautions | STK17B Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures. |
For Research Use Only. Not For Use In Diagnostic Procedures.
Provided below are standard protocols that you may find useful for product applications.
REFERENCES
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Rose JE, et al. Mol Med, 2010 Jul-Aug. PMID 20379614.The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. Landa I, et al. PLoS Genet, 2009 Sep. PMID 19730683.Regulation of the apoptosis-inducing kinase DRAK2 by cyclooxygenase-2 in colorectal cancer. Doherty GA, et al. Br J Cancer, 2009 Aug 4. PMID 19638987.Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development. Gatzka M, et al. J Immunol, 2009 Jul 1. PMID 19542440.Modulation of DRAK2 autophosphorylation by antigen receptor signaling in primary lymphocytes. Friedrich ML, et al. J Biol Chem, 2007 Feb 16. PMID 17182616.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.